The 36-Patient Acne Laser Pilot Published in 2026: A Source-Checked 2026 Briefing for Adults With Persistent Acne

The 36-patient acne laser pilot published July 10, 2026, was a three-arm randomized trial in moderate-to-severe inflammatory acne comparing intense pulsed light (IPL, filtered flashlamp pulses), pulsed dye laser (PDL, yellow-light vascular laser), and Q-switched 1064-nm Nd:YAG laser (short-pulse infrared laser). It found no significant difference between the three arms in lesion counts or severity scores at any session. Inflammatory acne means red, tender pimples, papules, and pustules that can leave marks and affect daily life. Springer Nature Link lists the trial as open-access in Lasers in Medical Science as article 41(1):144 Springer record.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What did the three arms test?
Why did daily life get better?
How are AviClear and Accure different?
Where does light fit beside proven treatment?
What should you ask before booking?

What did the three arms test?

The trial enrolled 36 patients with moderate-to-severe inflammatory acne and assigned about 12 patients each to IPL, PDL, or Q-switched 1064-nm Nd:YAG. Each device uses light and heat in a different way, but all target inflamed lesions and redness rather than removing oil glands.

The PubMed abstract reports P-values of 0.06-0.92 for between-group differences in lesion counts and severity scores, meaning no arm clearly cleared more acne PubMed abstract. For adults with persistent breakouts, the practical point is direct: none of these three options proved stronger in this small pilot.

Why did daily life get better?

Disability from acne fell significantly from baseline to two weeks after the final session. The PubMed abstract measures this with the Cardiff Acne Disability Index, a short survey about feelings, social life, and daily activities.

Lesion scores looked similar across arms, yet patients reported less burden. Routine care, fewer painful flares, reduced redness, and trial attention can improve comfort even before full clearance.

How are AviClear and Accure different?

The pilot tested vascular and photothermal devices. They differ from 1726-nm sebum-selective lasers, AviClear and Accure, which directly target sebaceous glands for mild-to-severe acne.

A separate prospective multicenter 1726-nm study of 104 patients found sustained moderate-to-severe acne reduction for at least one year across skin types, described as effective and well-tolerated JAAD study. Adults weighing light options should compare device type, not just the word laser.

Where does light fit beside proven treatment?

Current American Academy of Dermatology guidance still strongly recommends topical benzoyl peroxide, topical retinoids, topical or oral antibiotics or fixed-dose combinations, oral doxycycline, and isotretinoin for severe disease, according to Newswise coverage AAD guidance. Light and laser remain adjuncts, not first-line care.

That matters for persistent adult acne with scarring risk, missed workdays, or incomplete response to topicals. Prescription treatment controls bacteria, clogged pores, inflammation, and oil, while a device may add benefit for redness or stubborn inflammatory lesions.

What should you ask before booking?

Size and follow-up limit this pilot. About 12 patients per arm and disability follow-up at two weeks cannot prove long-term clearance, equivalence, or safety across skin types.

A 2026 dermatology safety review noted less procedural pain in the Q-switched Nd:YAG arm than with IPL or PDL, with effects generally limited to transient local effects. Use these checks at a consultation:.

Ask which wavelength you are offered and what tissue it targets.
Ask how many sessions, what downtime, and what pain control is used.
Ask how results will be tracked with lesion counts and photos.
Bring your current retinoid, antibiotic, isotretinoin, and sun-exposure history.